1 |
WHO. Coronavirus Disease (COVID-19) Dashboard [EB/OL]. [2021-02-21]. Data last updated: 04: 21pm CEST.
URL
|
2 |
Grasselli G, Greco M, Zanella A, et al. Risk factors associated with mortality among patients with COVID-19 in intensive care units in Lombardy, Italy [J].
JAMA Intern Med,
2020,
180(10): 1345-1355.
|
3 |
Yang X, Yu Y, Xu J, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study [J].
Lancet Respir Med,
2020,
8(5): 475-481.
|
4 |
Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China [J].
Lancet,
2020,
395(10223): 497-506.
|
5 |
Guerin C, Reignier J, Richard JC, et al. Prone positioning in severe acute respiratory distress syndrome [J].
N Engl J Med,
2013,
368(23): 2159-2168.
|
6 |
Ding L, Wang L, Ma W, et al. Efficacy and safety of early prone positioning combined with HFNC or NIV in moderate to severe ARDS: a multi-center prospective cohort study [J].
Crit Care,
2020,
24(1): 28.
|
7 |
Xu Z, Shi L, Wang Y, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome [J].
Lancet Respir Med,
2020,
8(4): 420-422.
|
8 |
Xu Q, Wang T, Qin X, et al. Early awake prone position combined with high-flow nasal oxygen therapy in severe COVID-19: a case series [J].
Crit Care,
2020,
24(1): 250.
|
9 |
Teng XB, Shen Y, Han MF, et al. The value of high-flow nasal cannula oxygen therapy in treating novel coronavirus pneumonia [J].
Eur J Clin Invest,
2021,
51(3): e13435.
|
10 |
Ferrando C, Mellado-Artigas R, Gea A, et al. Awake prone positioning does not reduce the risk of intubation in COVID-19 treated with high-flow nasal oxygen therapy: a multicenter, adjusted cohort study [J].
Crit Care,
2020,
24(1): 597.
|
11 |
Xie J, Tong Z, Guan X, et al. Critical care crisis and some recommendations during the COVID-19 epidemic in China [J].
Intensive Care Med,
2020,
46(5): 837-840.
|
12 |
Al-Samkari H, Karp LR, Dzik WH, et al. COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection [J].
Blood,
2020,
136(4): 489-500.
|
13 |
Kox M, Waalders NJB, Kooistra EJ, et al. Cytokine levels in critically ill patients with COVID-19 and other conditions [J].
JAMA,
2020,
324(15): 1565-1567.
|
14 |
刘茜, 王荣帅, 屈国强, 等. 新型冠状病毒肺炎死亡尸体系统解剖大体观察报告 [J].
法医学杂志,
2020,
36(1): 21-23.
|
15 |
Despres C, Brunin Y, Berthier F, et al. Prone positioning combined with high-flow nasal or conventional oxygen therapy in severe COVID-19 patients [J].
Crit Care,
2020,
24(1): 256.
|
16 |
Bower G, He H. Protocol for awake prone positioning in COVID-19 patients: to do it earlier, easier, and longer [J].
Crit Care,
2020,
24(1): 371.
|
17 |
Tan W, Xu DY, Xu MJ, et al. The efficacy and tolerance of prone positioning in non-intubation patients with acute hypoxemic respiratory failure and ARDS: a meta-analysis [J].
Ther Adv Respir Dis,
2021,
15: 1631378561.
|
18 |
Stilma W, Åkerman E, Artigas A, et al. Awake proning as an adjunctive therapy for refractory hypoxemia in non-intubated patients with COVID-19 acute respiratory failure: guidance from an International Group of Healthcare Workers [J].
Am J Trop Med Hyg,
2021,
104(5): 1676-1686.
|
19 |
Siemieniuk R, Chu DK, Kim LH, et al. Oxygen therapy for acutely ill medical patients: a clinical practice guideline [J].
BMJ,
2018,
363: k4169.
|
20 |
北京协和医院新型冠状病毒感染的肺炎诊治专家组. 北京协和医院关于"新型冠状病毒感染的肺炎"诊疗建议方案(V2.0) [J].
中华内科杂志,
2020,
59(3): 186-188.
|
21 |
倪忠, 秦浩, 李洁, 等. 新型冠状病毒肺炎患者经鼻高流量氧疗使用管理专家共识 [J].
中国呼吸与危重监护杂志,
2020,
19(2): 110-115.
|
22 |
Moller W, Feng S, Domanski U, et al. Nasal high flow reduces dead space [J].
J Appl Physiol (1985),
2017,
122(1): 191-197.
|
23 |
Roca O, Caralt B, Messika J, et al. An index combining respiratory rate and oxygenation to predict outcome of nasal high-flow therapy [J].
Am J Respir Crit Care Med,
2019,
199(11): 1368-1376.
|
24 |
郑瑞强, 胡明, 李绪言, 等. 重症新型冠状病毒肺炎呼吸治疗流程专家建议 [J/OL].
中华重症医学电子杂志,
2020,
6(1): 15-18.
|